These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
449 related items for PubMed ID: 25666447
41. Using the prototype willingness model to predict doping in sport. Whitaker L, Long J, Petróczi A, Backhouse SH. Scand J Med Sci Sports; 2014 Oct; 24(5):e398-405. PubMed ID: 25371934 [Abstract] [Full Text] [Related]
42. Korean national athletes' knowledge, practices, and attitudes of doping: a cross-sectional study. Kim T, Kim YH. Subst Abuse Treat Prev Policy; 2017 Feb 14; 12(1):7. PubMed ID: 28196542 [Abstract] [Full Text] [Related]
43. Self-control, self-regulation, and doping in sport: a test of the strength-energy model. Chan DK, Lentillon-Kaestner V, Dimmock JA, Donovan RJ, Keatley DA, Hardcastle SJ, Hagger MS. J Sport Exerc Psychol; 2015 Apr 14; 37(2):199-206. PubMed ID: 25996110 [Abstract] [Full Text] [Related]
44. Prediction profiles for nutritional supplement use among young German elite athletes. Dietz P, Ulrich R, Niess A, Best R, Simon P, Striegel H. Int J Sport Nutr Exerc Metab; 2014 Dec 14; 24(6):623-31. PubMed ID: 24901677 [Abstract] [Full Text] [Related]
45. Inevitable? Doping attitudes among Berliners in 2011: the role of socialist state socialisation and athlete experience. Wagner GG, Ziebarth NR. Eur J Public Health; 2016 Jun 14; 26(3):520-2. PubMed ID: 27056894 [Abstract] [Full Text] [Related]
46. An alternative approach to the prevention of doping in cycling. Aubel O, Ohl F. Int J Drug Policy; 2014 Nov 14; 25(6):1094-102. PubMed ID: 25440912 [Abstract] [Full Text] [Related]
47. The sports psychiatrist and performance-enhancing drugs. Creado S, Reardon C. Int Rev Psychiatry; 2016 Dec 14; 28(6):564-571. PubMed ID: 27310472 [Abstract] [Full Text] [Related]
48. Young athletes' awareness and monitoring of anti-doping in daily life: Does motivation matter? Chan DK, Donovan RJ, Lentillon-Kaestner V, Hardcastle SJ, Dimmock JA, Keatley DA, Hagger MS. Scand J Med Sci Sports; 2015 Dec 14; 25(6):e655-63. PubMed ID: 25441263 [Abstract] [Full Text] [Related]
49. ["Enjoy the Sport - Schools against doping and drug dependence": a health education intervention in secondary schools]. Masala D, D'Egidio V, Iona T, La Torre G. Ig Sanita Pubbl; 2019 Dec 14; 75(4):271-282. PubMed ID: 31887733 [Abstract] [Full Text] [Related]
50. Nutritional supplement and doping use in sport: Possible underlying social cognitive processes. Barkoukis V, Lazuras L, Lucidi F, Tsorbatzoudis H. Scand J Med Sci Sports; 2015 Dec 14; 25(6):e582-8. PubMed ID: 25556707 [Abstract] [Full Text] [Related]
51. Performance effects of acute β-alanine induced paresthesia in competitive cyclists. Bellinger PM, Minahan CL. Eur J Sport Sci; 2016 Dec 14; 16(1):88-95. PubMed ID: 25636080 [Abstract] [Full Text] [Related]
52. Doping in Two Elite Athletics Competitions Assessed by Randomized-Response Surveys. Ulrich R, Pope HG, Cléret L, Petróczi A, Nepusz T, Schaffer J, Kanayama G, Comstock RD, Simon P. Sports Med; 2018 Jan 14; 48(1):211-219. PubMed ID: 28849386 [Abstract] [Full Text] [Related]
53. Self-admitted behavior and perceived use of performance-enhancing vs psychoactive drugs among competitive athletes. Uvacsek M, Nepusz T, Naughton DP, Mazanov J, Ránky MZ, Petróczi A. Scand J Med Sci Sports; 2011 Apr 14; 21(2):224-34. PubMed ID: 19903314 [Abstract] [Full Text] [Related]
54. Motivational and social cognitive predictors of doping intentions in elite sports: an integrated approach. Barkoukis V, Lazuras L, Tsorbatzoudis H, Rodafinos A. Scand J Med Sci Sports; 2013 Oct 14; 23(5):e330-40. PubMed ID: 23574429 [Abstract] [Full Text] [Related]
55. Elite athletes' attitudes towards the use of placebo-induced performance enhancement in sports. Bérdi M, Köteles F, Hevesi K, Bárdos G, Szabo A. Eur J Sport Sci; 2015 Oct 14; 15(4):315-21. PubMed ID: 25189187 [Abstract] [Full Text] [Related]
56. Sport supplement use predicts doping attitudes and likelihood via sport supplement beliefs. Hurst P, Kavussanu M, Boardley I, Ring C. J Sports Sci; 2019 Aug 14; 37(15):1734-1740. PubMed ID: 30860956 [Abstract] [Full Text] [Related]
57. National doping prevention guidelines: Intent, efficacy and lessons learned - A 4-year evaluation. Wippert PM, Fließer M. Subst Abuse Treat Prev Policy; 2016 Oct 10; 11(1):35. PubMed ID: 27724975 [Abstract] [Full Text] [Related]
58. Psychological mechanisms underlying doping attitudes in sport: motivation and moral disengagement. Hodge K, Hargreaves EA, Gerrard D, Lonsdale C. J Sport Exerc Psychol; 2013 Aug 10; 35(4):419-32. PubMed ID: 23966451 [Abstract] [Full Text] [Related]
59. Influences of perfectionism and motivational climate on attitudes towards doping among Korean national athletes: a cross sectional study. Bae M, Yoon J, Kang H, Kim T. Subst Abuse Treat Prev Policy; 2017 Dec 12; 12(1):52. PubMed ID: 29233177 [Abstract] [Full Text] [Related]
60. Value of basal serum cortisol to detect corticosteroid-induced adrenal insufficiency in elite cyclists. Guinot M, Duclos M, Idres N, Souberbielle JC, Megret A, Le Bouc Y. Eur J Appl Physiol; 2007 Feb 12; 99(3):205-16. PubMed ID: 17089154 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]